Cellares’ new IDMO Smart Factory in Leiden, Netherlands, expands commercial-scale manufacturing capacity for European cell therapy patient populations through a standardized, automated, and highly sca ...

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...

Cell therapy manufacturing is patient-specific and time-sensitive, making regional production capacity increasingly important.

Cellares is gearing up to unveil a major investment it is making here in the great Garden State. As NJBIZ reported in August, the San Francisco-headquartered cell therapy manufacturer secured $255 ...

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and commercial-scale cell therapy manufacturing, announced ...

Cellares, in collaboration with Mitsui Fudosan, a Japanese real estate developer, established Japan’s first next-gen commercial production site for CAR-T cell therapies. The facility is under ...

SOUTH SAN FRANCISCO, Calif., Aug. 23, 2023 /PRNewswire/ -- Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy ...

Autolus Therapeutics, a commercial-stage biopharmaceutical company, has announced plans to assess the feasibility of Cellares ...